Non-immunoglobulin synthetic binding proteins for oncology

TI David, NB Pestov, TV Korneenko, NA Barlev - Biochemistry (Moscow), 2023 - Springer
Extensive application of technologies like phage display in screening peptide and protein
combinatorial libraries has not only facilitated creation of new recombinant antibodies but …

Hetero-tricyclic Compounds as KRAS Inhibitors for Treating Cancer

RW Sabnis - ACS Medicinal Chemistry Letters, 2023 - ACS Publications
Hetero-tricyclic Compounds as KRAS Inhibitors for Treating Cancer Page 1 Hetero-tricyclic
Compounds as KRAS Inhibitors for Treating Cancer Ram W. Sabnis* Cite This: https://doi.org/10.1021/acsmedchemlett.3c00347 …

Novel Quinoline Compounds as KRAS Inhibitors for Treating Cancer

RW Sabnis - ACS Medicinal Chemistry Letters, 2023 - ACS Publications
Novel Quinoline Compounds as KRAS Inhibitors for Treating Cancer Page 1 Novel Quinoline
Compounds as KRAS Inhibitors for Treating Cancer Ram W. Sabnis* Cite This: ACS Med. Chem …

Novel Tricyclic Compounds as KRAS Inhibitors for Treating Cancer

RW Sabnis - ACS Medicinal Chemistry Letters, 2023 - ACS Publications
Novel Tricyclic Compounds as KRAS Inhibitors for Treating Cancer Page 1 Novel Tricyclic
Compounds as KRAS Inhibitors for Treating Cancer Ram W. Sabnis* Cite This: ACS Med …

Novel Pyrazoloquinoline Compounds as KRAS Inhibitors for Treating Cancer

RW Sabnis - ACS Medicinal Chemistry Letters, 2023 - ACS Publications
Novel Pyrazoloquinoline Compounds as KRAS Inhibitors for Treating Cancer Page 1 Novel
Pyrazoloquinoline Compounds as KRAS Inhibitors for Treating Cancer Ram W. Sabnis* Cite …